Johnson Pharmacare Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 233635, "name": "Johnson Pharma", "stock_name": "Johnson Pharma", "full_name": "Johnson Pharmacare Ltd", "name_url": "stocks-analysis/johnson-pharma", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "0.48", "chg": 0.01, "chgp": "2.13%", "dir": 1, "prev_price": "0.47", "mcapval": "26.00 Cr", "mcap": "Micro Cap", "scripcode": 532154, "symbol": "", "ind_name": "Diversified Commercial Services", "ind_code": 49, "sector_id": 17, "indexname": "India SENSEX", "isin": "INE560F01022", "curr_date": "Jul 17, 03:30 PM", "curr_time": "08:51 AM", "last_traded_at": "Jul 17, 03:30 PM IST", "bse_nse_vol": "4.49 lacs", "exc_status": "Active", "traded_date": "Jul 17, 2026", "traded_date_str": "2026 07 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/johnson-pharma-233635-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Johnson Pharmacare Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/johnson-pharmacare-ltd-is-rated-strong-sell-4096260", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/JohnsonPharmaca_mojoScore_4096260.png", "date": "2026-07-10 10:10:51", "description": "Johnson Pharmacare Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 29 May 2026, reflecting a comprehensive assessment of the company’s current position. However, all fundamentals, returns, and financial metrics discussed below are as of 10 July 2026, providing investors with the latest insights into the stock’s performance and outlook." }, { "title": "Johnson Pharmacare Declines 1.85%: Downgrade and Weak Fundamentals Weigh", "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-declines-185-downgrade-and-weak-fundamentals-weigh-4053103", "imagepath": "", "date": "2026-06-14 15:00:06", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Quality grade downgraded to Below Average, highlighting fundamental weaknesses</p>\n <p><strong>1 June:</strong> MarketsMOJO assigns Strong Sell rating amid weak fundamentals and bearish technicals</p>\n <p><strong>5 June:</strong> Week closes at Rs.0.53, down 1.85% for the week</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.54</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.0.53</div><div class=\"stat-change negative\">-1.85%</..." }, { "title": "Johnson Pharmacare Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals", "link": "https://www.marketsmojo.com/news/stock-recommendation/johnson-pharmacare-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-4025236", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JohnsonPharmaca_mojoScore_4025236.png", "date": "2026-06-01 08:03:05", "description": "Johnson Pharmacare Ltd has been assigned a Strong Sell rating by MarketsMOJO as of 29 May 2026, reflecting deteriorating fundamentals and a bearish technical outlook. The downgrade from a previously ungraded status is driven by a comprehensive reassessment across quality, valuation, financial trend, and technical parameters, signalling heightened risk for investors in this micro-cap stock." }, { "title": "Johnson Pharmacare Ltd Quality Grade Downgrade Highlights Fundamental Weaknesses", "link": "https://www.marketsmojo.com/news/stocks-in-action/johnson-pharmacare-ltd-quality-grade-downgrade-highlights-fundamental-weaknesses-4024917", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/JohnsonPharmaca_qualitydot_4024917.png", "date": "2026-06-01 08:00:17", "description": "Johnson Pharmacare Ltd has recently undergone a significant downgrade in its quality grading, shifting from a non-qualifying status to a below average rating as of 29 May 2026. This change reflects deteriorating business fundamentals, particularly in profitability, capital efficiency, and financial stability, raising concerns for investors amid a challenging market backdrop." }, { "title": "Johnson Pharmacare Q4 FY26: Alarming ₹55.61 Crore Loss Raises Serious Viability Concerns", "link": "https://www.marketsmojo.com/news/result-analysis/johnson-pharmacare-q4-fy26-alarming-5561-crore-loss-raises-serious-viability-concerns-4022172", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JohnsonPharmaca_quaterlyResult_4022172.png", "date": "2026-05-29 17:04:35", "description": "Johnson Pharmacare Limited reported a catastrophic fourth quarter for FY26, posting a net loss of ₹55.61 crores in Q4 FY26—a dramatic deterioration from the ₹0.51 crore loss in Q4 FY25. The micro-cap diversified commercial services company, with a market capitalisation of just ₹30.00 crores, continues to generate zero revenue whilst accumulating substantial losses, raising fundamental questions about operational viability and business sustainability." } ], "total": 85, "sid": "233635", "stock_news_url": "https://www.marketsmojo.com/news/johnson-pharmacare-233635" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "13-Jul-2026", "details": "Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulation 2018 for the quarter ended on 30th June 2026.", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "26-Jun-2026", "details": "Intimation of Closure of Trading Window", "source": "BSE" }, { "caption": "Submission Of Audited Financials Results Of Jhonson Pharmacare Ltd. For The Quarter And Year Ended On March 31St 2026", "datetime": "19-Jun-2026", "details": "Submission of Audited Financial Results of Jhonson Pharmacare ltd for the quarter and year ended on March 31st March 2026", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> stock split, ex-date: 05 Jan 22", "dt": "2022-01-05", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Johnson Pharmacare Ltd has announced <strong>1:10</strong> bonus issue, ex-date: 07 Apr 22", "dt": "2022-04-07", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

1 June: Quality grade downgraded to Below Average, highlighting fundamental weaknesses

1 June: MarketsMOJO assigns Strong Sell rating amid weak fundamentals and bearish technicals

5 June: Week closes at Rs.0.53, down 1.85% for the week

-1.85%Read full news article

Johnson Pharmacare Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-06-01 08:03:05

Johnson Pharmacare Ltd has been assigned a Strong Sell rating by MarketsMOJO as of 29 May 2026, reflecting deteriorating fundamentals and a bearish technical outlook. The downgrade from a previously ungraded status is driven by a comprehensive reassessment across quality, valuation, financial trend, and technical parameters, signalling heightened risk for investors in this micro-cap stock.

Read full news article

Johnson Pharmacare Ltd Quality Grade Downgrade Highlights Fundamental Weaknesses

2026-06-01 08:00:17

Johnson Pharmacare Ltd has recently undergone a significant downgrade in its quality grading, shifting from a non-qualifying status to a below average rating as of 29 May 2026. This change reflects deteriorating business fundamentals, particularly in profitability, capital efficiency, and financial stability, raising concerns for investors amid a challenging market backdrop.

Read full news article

Johnson Pharmacare Q4 FY26: Alarming ₹55.61 Crore Loss Raises Serious Viability Concerns

2026-05-29 17:04:35

Johnson Pharmacare Limited reported a catastrophic fourth quarter for FY26, posting a net loss of ₹55.61 crores in Q4 FY26—a dramatic deterioration from the ₹0.51 crore loss in Q4 FY25. The micro-cap diversified commercial services company, with a market capitalisation of just ₹30.00 crores, continues to generate zero revenue whilst accumulating substantial losses, raising fundamental questions about operational viability and business sustainability.

Read full news article